Healthcare - Biotechnology - NASDAQ - DE
$ 2.54
-4.87 %
$ 570 M
Market Cap
-1.97
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
26.48%
EBIT
Estimate
15.84%
Net Income
Estimate
36.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
CureVac N.V.
CVAC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CVAC
EBIT FORECAST
EBIT Forecast Chart CVAC
NET INCOME FORECAST
Net Income Chart CVAC